Marvio Abreu

Marvio Abreu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2024 in Journal of Animal Science and Biotechnology
Verified
Journal Article
Open access
PDF file
MDMarcos Elias Duarte
Marcos Elias Duarte
WPWanpuech Parnsen
Wanpuech Parnsen
Shihai ZhangShihai Zhang
Shihai Zhang
MAMarvio Abreu
Marvio Abreu
Sung Woo KimSung Woo Kim
Sung Woo Kim
Background: Low crude protein (CP) formulations with supplemental amino acids (AA) are used to enhance intestinal health, reduce costs, minimize environmental impact, and maintain growth performance of pigs. However, extensive reduction of dietary CP can compromise growth performance due to limited synthesis of non-essential AA and limited availability of bioactive compounds from protein supplements even when AA requirements are met. Moreover, implementing a low CP formulation can increase the net energy (NE) content in feeds causing excessive fat deposition. Additional supplementation of functional AA, coupled with low CP formulation could further enhance intestinal health and glucose metabolism, improving nitrogen utilization, and growth performance. Three experiments were conducted to evaluate the effects of low CP formulations with supplemental AA on the intestinal health and growth performance of growing-finishing pigs. Methods: In Exp. 1, 90 pigs (19.7 ± 1.1 kg, 45 barrows and 45 gilts) were assigned to 3 treatments: CON (18.0% CP, supplementing Lys, Met, and Thr), LCP (16.0% CP, supplementing Lys, Met, Thr, Trp, and Val), and LCPT (16.1% CP, LCP + 0.05% SID Trp). In Exp. 2, 72 pigs (34.2 ± 4.2 kg BW) were assigned to 3 treatments: CON (17.7% CP, meeting the requirements of Lys, Met, Thr, and Trp); LCP (15.0% CP, meeting Lys, Thr, Trp, Met, Val, Ile, and Phe); and VLCP (12.8% CP, meeting Lys, Thr, Trp, Met, Val, Ile, Phe, His, and Leu). In Exp. 3, 72 pigs (54.1 ± 5.9 kg BW) were assigned to 3 treatments and fed experimental diets for 3 phases (grower 2, finishing 1, and finishing 2). Treatments were CON (18.0%, 13.8%, 12.7% CP for 3 phases; meeting Lys, Met, Thr, and Trp); LCP (13.5%, 11.4%, 10.4% CP for 3 phases; meeting Lys, Thr, Trp, Met, Val, Ile, and Phe); and LCPG (14.1%, 12.8%, 11.1% CP for 3 phases; LCP + Glu to match SID Glu with CON). All diets had 2.6 Mcal/kg NE. Results: In Exp. 1, overall, the growth performance did not differ among treatments. The LCPT increased (P < 0.05) Claudin-1 expression in the duodenum and jejunum. The LCP and LCPT increased (P < 0.05) CAT-1, 4F2hc, and B0AT expressions in the jejunum. In Exp. 2, overall, the VLCP reduced (P < 0.05) G:F and BUN. The LCP and VLCP increased (P < 0.05) the backfat thickness (BFT). In Exp. 3, overall, growth performance and BFT did not differ among treatments. The LCPG reduced (P < 0.05) BUN, whereas increased the insulin in plasma. The LCP and LCPG reduced (P < 0.05) the abundance of Streptococcaceae, whereas the LCP reduced (P < 0.05) Erysipelotrichaceae, and the alpha diversity. Conclusions: When implementing low CP formulation, CP can be reduced by supplementation of Lys, Thr, Met, Trp, Val, and Ile without affecting the growth performance of growing-finishing pigs when NE is adjusted to avoid increased fat deposition. Supplementation of Trp above the requirement or supplementation of Glu in low CP formulation seems to benefit intestinal health as well as improved nitrogen utilization and glucose metabolism.

28 October 2020 in Animals
Verified
Journal Article
Open access
PDF file
LRLeticia Mendonça Rodrigues
Leticia Mendonça Rodrigues
TNTúlio Otávio de Araújo Lima Neto
Túlio Otávio de Araújo Lima Neto
CGCesar Augusto Pospissil Pospissil Garbossa
Cesar Augusto Pospissil Pospissil Garbossa
CSClaudia Silva
Claudia Silva
DGDino Garcez
Dino Garcez
VCVinícius de Souza Cantarelli
Vinícius de Souza Cantarelli
Benzoic acid (BA) and essential oils (EOs) (thymol, 2-methoxyphenol, eugenol, piperine, and curcumin) are being studied to minimize the impairment of gastrointestinal functions in weanling piglets. This study evaluates the effects of combining BA and EO on the performance and intestinal health of piglets challenged with E. coli F4 (1 mL, 106 CFU/mL). In total, 270 weaned piglets were used in a randomized block design with six treatments: positive control, with 40 mg/kg colistin (PC); negative control, without the growth promoter (NC); negative control +5 g/kg benzoic acid (BA); negative control +2 g/kg combination of BA+EO (BA+EO2); negative control +3 g/kg combination of BA+EO (BA+EO3); negative control +4 g/kg combination of BA+EO (BA+EO4). BA+EO3 presented a greater average daily gain (ADG) (p = 0.0013) and better feed-to-gain ratio (p = 0.0138), compared to NC, from 21 to 35 days age. For the total period, BA, BA+EO3, and BA+EO4 were similar to PC and superior to NC for ADG (p = 0.0002) and final body weight (BW) (p = 0.0002). No difference (p > 0.05) was verified for diarrhea, microbial population, production of volatile fatty acids, pH, weight of organs, cellular proliferation, and cholecystokinin count. NC and BA+EO4 resulted in a higher villus height in the jejunum (p = 0.0120) compared to BA+EO3. The use of BA or the combination of BA and EO at 3 g/kg provides improved performance, aside from being an economically viable alternative to replace colistin.

9 December 2024 in South African Journal of Animal Science
Verified
Journal Article
Open access
PDF file
LFL. Da Silva Fonseca
L. Da Silva Fonseca
RMR.H.R. Moreira
R.H.R. Moreira
JPJ.H.P. Palencia
J.H.P. Palencia
ELE. Lanferdini
E. Lanferdini
RCR.F. Chaves
R.F. Chaves
MAMarvio Abreu
Marvio Abreu
To evaluate the effects of glutamine (Gln) supplementation on sow performance during late gestation and lactation and their offspring, eighty pregnant, multiparous sows of a commercial hybrid line were used in a completely randomized, 2 × 2 experimental design at the end of gestation and lactation, respectively. Females were subjected to a control diet or a Gln-supplemented diet (1% of Lglutamine) from 85 d of gestation until farrowing. During lactation, the dietary treatment groups were CON_C: without Gln supplementation; CON_G: Gln only during lactation; GLN_C: Gln only during gestation; GLN_ GLN: Gln during gestation and lactation. At 105 d of gestation, there was no statistical difference regarding the body weight of the sows, however, sows fed the Gln-supplemented diet had greater backfat thickness at P1 and loin depth at P2 than control sows. Placental weight and efficiency showed no effect between treatments. Litters born from Gln-supplemented sows tended to be heavier at birth compared to control litters, reducing the probability of piglets weighing less than 1.5 kg. In addition, litters from supplemented sows had a lower standard deviation of BW at birth. There were no effects of dietary treatments on the performance of sows and offspring during the lactation period. Maternal Gln supplementation during late gestation improved piglet weight and litter uniformity at birth without affecting sow body composition after farrowing.